Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.

Autores:: Matta, Salim
Arango, Álvaro I.
Visbal, Jorge

Tipo de recurso:: Article of journal

Fecha de publicación:: 2001

Institución:: Universidad de Córdoba

Repositorio:: Repositorio Institucional Unicórdoba

Idioma:: spa

id	UCORDOBA2_25a3aa92f5765867d24a527a6db77ec0
oai_identifier_str	oai:repositorio.unicordoba.edu.co:ucordoba/5749
network_acronym_str	UCORDOBA2
network_name_str	Repositorio Institucional Unicórdoba
repository_id_str
dc.title.spa.fl_str_mv	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
dc.title.translated.eng.fl_str_mv	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
title	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
spellingShingle	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
title_short	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
title_full	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
title_fullStr	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
title_full_unstemmed	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
title_sort	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
dc.creator.fl_str_mv	Matta, Salim Arango, Álvaro I. Visbal, Jorge
dc.contributor.author.spa.fl_str_mv	Matta, Salim Arango, Álvaro I. Visbal, Jorge
publishDate	2001
dc.date.accessioned.none.fl_str_mv	2001-07-01 00:00:00 2022-07-01T20:59:58Z
dc.date.available.none.fl_str_mv	2001-07-01 00:00:00 2022-07-01T20:59:58Z
dc.date.issued.none.fl_str_mv	2001-07-01
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.eng.fl_str_mv	Journal article
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_6501
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv	Text
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/ARTREF
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.issn.none.fl_str_mv	0122-0268
dc.identifier.uri.none.fl_str_mv	https://repositorio.unicordoba.edu.co/handle/ucordoba/5749
dc.identifier.doi.none.fl_str_mv	10.21897/rmvz.528
dc.identifier.url.none.fl_str_mv	https://doi.org/10.21897/rmvz.528
dc.identifier.eissn.none.fl_str_mv	1909-0544
identifier_str_mv	0122-0268 10.21897/rmvz.528 1909-0544
url	https://repositorio.unicordoba.edu.co/handle/ucordoba/5749 https://doi.org/10.21897/rmvz.528
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	Arango A I. Chlamydia y Rickettsia. En Máttar S, & Melo A, Editores. Bacteriología clínica: estudio etiológico de las enfermedades infecciosas de origen bacteriano. 1998; Editorial CEJA. Bogotá. Baehr W, Zhang, Y, Joseph T, Su H, Nano FE, Everett DE, et al: Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci USA 1988; 85:4000-4004. http://dx.doi.org/10.1073/pnas.85.11.4000 Bavoil P: Invation and Intracellular Growth of Chlamydia Species. En: Iglewski BH, Clark VI (Eds): Molecular Basis of Bacterial Pathogenesis. Academic Press. 1990. Bergeys Manual of Determinative Bacteriology, Ninth Edition, Willians & Wilkins Baltimore, USA 1994; 351. Black C. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10:160-184. Brunham RC, Peeling RW. Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect Agents Dis 1994; 3:218-33. Centers for Disease Control, Division of Sexually Transmitted Diseses: STD treatment guidelines. MMWR 1995; 34(4S). Dahlen G, J. Boman, L. S. Birgander, and P. Lindblom. LP (A) lipropotein, IgG, IgA, IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 1995; 114 :165-174. http://dx.doi.org/10.1016/0021-9150(94)05480-7 Fong I, Chiu B, Viira E, et al. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 1997; 35:48-52. Kapusnik-Uner JE, Sande MA, Chambers HF. Tetracyclines, Choramphenicol, Erytromycin, and Miscellaneous Antibacterial Agents in Goodman & Gilman's The pharmacological Basis of Therapeutics. Ninth Edition. The Mc Graw-Hill Companies. 1996; 1123-1153. Kuo CC, Shor A, Campbell L, Fukushi H, Patton D, Grayston JT. Demonstration of Chlamydia pneumoniae in Atherosclerotic Lesions of Coronary Arteries. J Infect Dis 1993; 167:841-9. http://dx.doi.org/10.1093/infdis/167.4.841 Magid D, Douglas JM, Schwartz JS. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann Intern Med 1996; 124:389-99. http://dx.doi.org/10.7326/0003-4819-124-4-199602150-00002 McClarty G. Chlamydiae and the biochemistry of intracellular parasitism. Trends Microbiol 1994; 2:157-64. http://dx.doi.org/10.1016/0966-842X(94)90665-3 Melnick S. L, E. Shahar A. R. Fulsom J. T. Grayston P. D. Sorlie F. P. Wang. and M. Szkzo. Past infection by Chlamydia pneumoniae strain: TWAR and asymptomatic carotid atherosclerosis: atherosclerosis risk in communities (ARIC): study investigators. Am J Med 1993; 95:499-504. http://dx.doi.org/10.1016/0002-9343(93)90332-J Mendall M. A, D. Carrington D. Strachan, P. Patel, N. Molineaux J. Levi, T. Toosey A. K. Camm, and T. C. Northfield. Chlamydia pneumoniae: risk factor for seropositivy and association with coronary artery disease. J Infect 1995; 30:121-128. http://dx.doi.org/10.1016/S0163-4453(95)80006-9 Mlot Ch. Probing Chamydia connection to atheroesclerosis. Asm- News 1996; 62:521. Morré SA, Sillekens P, Jacobs MV, Van Aarle P, Blok S, Van Gemen B, Jan M, Walboomers M, Chris J, Meijer LM, And Adriaan J, Van den Brule C. RNA Amplification by Nucleic Acid SequenceBased Amplification with an Internal Standard Enables Reliable Detection of Chlamydia trachomatis in Cervical Scrapings and Urine Samples. J Clin Microbiol. 1996; 34:3108-3114. Morrison RP, Belland RJ, Lyng D, Caldwell HD: Chlamydial disease pathogenesis. The 57 kDa chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 1989; 25:170:1271 Ossewaarde JM, Plantema FHF, Rieffe M, Nawrocki RP, de Vries A, Van Loon AM. Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis. Eur J Clin Microbiol Infect Dis 1992; 11:693-7. http://dx.doi.org/10.1007/BF01989972 Patel P, M. A. Mendall D. Carrington D. P. Strauchan E. Leatham, N. Molienaux, J. Levi, C. Blakeston, C. A. Seymour, A. K. Camm et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factor. Br Med J 1995; 311:711-714. http://dx.doi.org/10.1136/bmj.311.7007.711 Peeling RW. Chlamydia trachomatis and Neisseria gonorrhoeae: Pathogens in retreat? Current Opinion in Infections Diseases 1995; 8:26-34. http://dx.doi.org/10.1097/00001432-199502000-00006 Reese R, Bets R.Sulfonamides and TrimethropimSulfamethoxazole in Handbook of Antibiotics. Second Edition. Little, Brown and Company. Boston & New York. USA. 1993; 271-427. Schachter J, Grossman M, Azimi PH: Serology of Chlamydia trachomatis in infants. J Infect Dis 1982; 146: 53. http://dx.doi.org/10.1093/infdis/146.4.530 Verkooyen RP, Luijendijk A, Huisman WM, Goessens WHF, Kluytmans JAJW, Van RijsoortVos JH, Verbrugh HA. Detection of PCR Inhibitors in Cervical Specimens by Using the Amplicor Chlamydia trachomatis Assay. J Clin Microbiol. 1996; 34:3072-3074. Woods ML, Robinson EN Jr., McGee ZA, Hitchcok PJ. Chlamydiae-Genital and Respiratory Pathogens in Mechanisms of Microbial Disease. Shaechter M, Medoff G, Eisenstein B I. Second Edition. Williams & Wilkins. Baltimore, Maryland. USA. 1989; 350-357.
dc.relation.bitstream.none.fl_str_mv	https://revistamvz.unicordoba.edu.co/article/download/528/596
dc.relation.citationedition.spa.fl_str_mv	Núm. 2 , Año 2001 : Revista MVZ Córdoba volumen 6(2) Julio-Diciembre 2001
dc.relation.citationissue.spa.fl_str_mv	2
dc.relation.citationvolume.spa.fl_str_mv	6
dc.relation.ispartofjournal.spa.fl_str_mv	Revista MVZ Córdoba
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Universidad de Córdoba
dc.source.spa.fl_str_mv	https://revistamvz.unicordoba.edu.co/article/view/528
institution	Universidad de Córdoba
bitstream.url.fl_str_mv	https://repositorio.unicordoba.edu.co/bitstreams/4ce1becb-566d-405f-95f2-e6c0c5da15ba/download
bitstream.checksum.fl_str_mv	3d791b0ad6968cbc0088d6252df219c8
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Universidad de Córdoba
repository.mail.fl_str_mv	bdigital@metabiblioteca.com
_version_	1839636153098043392
spelling	Matta, Salimddd02360-1577-4505-b4e1-5907f9430f5d-1Arango, Álvaro I.ac73a7d8-ebd6-4310-baec-a955ac4cbfbb-1Visbal, Jorge9f4317f6-68e2-4c97-82d1-d79177fb6e78-12001-07-01 00:00:002022-07-01T20:59:58Z2001-07-01 00:00:002022-07-01T20:59:58Z2001-07-010122-0268https://repositorio.unicordoba.edu.co/handle/ucordoba/574910.21897/rmvz.528https://doi.org/10.21897/rmvz.5281909-0544application/pdfspaUniversidad de Córdobahttps://creativecommons.org/licenses/by-nc-sa/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2https://revistamvz.unicordoba.edu.co/article/view/528Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.Artículo de revistaJournal articleinfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/publishedVersionTexthttp://purl.org/redcol/resource_type/ARTREFhttp://purl.org/coar/version/c_970fb48d4fbd8a85Arango A I. Chlamydia y Rickettsia. En Máttar S, & Melo A, Editores. Bacteriología clínica: estudio etiológico de las enfermedades infecciosas de origen bacteriano. 1998; Editorial CEJA. Bogotá.Baehr W, Zhang, Y, Joseph T, Su H, Nano FE, Everett DE, et al: Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci USA 1988; 85:4000-4004. http://dx.doi.org/10.1073/pnas.85.11.4000Bavoil P: Invation and Intracellular Growth of Chlamydia Species. En: Iglewski BH, Clark VI (Eds): Molecular Basis of Bacterial Pathogenesis. Academic Press. 1990.Bergeys Manual of Determinative Bacteriology, Ninth Edition, Willians & Wilkins Baltimore, USA 1994; 351.Black C. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10:160-184.Brunham RC, Peeling RW. Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect Agents Dis 1994; 3:218-33.Centers for Disease Control, Division of Sexually Transmitted Diseses: STD treatment guidelines. MMWR 1995; 34(4S).Dahlen G, J. Boman, L. S. Birgander, and P. Lindblom. LP (A) lipropotein, IgG, IgA, IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 1995; 114 :165-174. http://dx.doi.org/10.1016/0021-9150(94)05480-7Fong I, Chiu B, Viira E, et al. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 1997; 35:48-52.Kapusnik-Uner JE, Sande MA, Chambers HF. Tetracyclines, Choramphenicol, Erytromycin, and Miscellaneous Antibacterial Agents in Goodman & Gilman's The pharmacological Basis of Therapeutics. Ninth Edition. The Mc Graw-Hill Companies. 1996; 1123-1153.Kuo CC, Shor A, Campbell L, Fukushi H, Patton D, Grayston JT. Demonstration of Chlamydia pneumoniae in Atherosclerotic Lesions of Coronary Arteries. J Infect Dis 1993; 167:841-9. http://dx.doi.org/10.1093/infdis/167.4.841Magid D, Douglas JM, Schwartz JS. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann Intern Med 1996; 124:389-99. http://dx.doi.org/10.7326/0003-4819-124-4-199602150-00002McClarty G. Chlamydiae and the biochemistry of intracellular parasitism. Trends Microbiol 1994; 2:157-64. http://dx.doi.org/10.1016/0966-842X(94)90665-3Melnick S. L, E. Shahar A. R. Fulsom J. T. Grayston P. D. Sorlie F. P. Wang. and M. Szkzo. Past infection by Chlamydia pneumoniae strain: TWAR and asymptomatic carotid atherosclerosis: atherosclerosis risk in communities (ARIC): study investigators. Am J Med 1993; 95:499-504. http://dx.doi.org/10.1016/0002-9343(93)90332-JMendall M. A, D. Carrington D. Strachan, P. Patel, N. Molineaux J. Levi, T. Toosey A. K. Camm, and T. C. Northfield. Chlamydia pneumoniae: risk factor for seropositivy and association with coronary artery disease. J Infect 1995; 30:121-128. http://dx.doi.org/10.1016/S0163-4453(95)80006-9Mlot Ch. Probing Chamydia connection to atheroesclerosis. Asm- News 1996; 62:521.Morré SA, Sillekens P, Jacobs MV, Van Aarle P, Blok S, Van Gemen B, Jan M, Walboomers M, Chris J, Meijer LM, And Adriaan J, Van den Brule C. RNA Amplification by Nucleic Acid SequenceBased Amplification with an Internal Standard Enables Reliable Detection of Chlamydia trachomatis in Cervical Scrapings and Urine Samples. J Clin Microbiol. 1996; 34:3108-3114.Morrison RP, Belland RJ, Lyng D, Caldwell HD: Chlamydial disease pathogenesis. The 57 kDa chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 1989; 25:170:1271Ossewaarde JM, Plantema FHF, Rieffe M, Nawrocki RP, de Vries A, Van Loon AM. Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis. Eur J Clin Microbiol Infect Dis 1992; 11:693-7. http://dx.doi.org/10.1007/BF01989972Patel P, M. A. Mendall D. Carrington D. P. Strauchan E. Leatham, N. Molienaux, J. Levi, C. Blakeston, C. A. Seymour, A. K. Camm et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factor. Br Med J 1995; 311:711-714. http://dx.doi.org/10.1136/bmj.311.7007.711Peeling RW. Chlamydia trachomatis and Neisseria gonorrhoeae: Pathogens in retreat? Current Opinion in Infections Diseases 1995; 8:26-34. http://dx.doi.org/10.1097/00001432-199502000-00006Reese R, Bets R.Sulfonamides and TrimethropimSulfamethoxazole in Handbook of Antibiotics. Second Edition. Little, Brown and Company. Boston & New York. USA. 1993; 271-427.Schachter J, Grossman M, Azimi PH: Serology of Chlamydia trachomatis in infants. J Infect Dis 1982; 146: 53. http://dx.doi.org/10.1093/infdis/146.4.530Verkooyen RP, Luijendijk A, Huisman WM, Goessens WHF, Kluytmans JAJW, Van RijsoortVos JH, Verbrugh HA. Detection of PCR Inhibitors in Cervical Specimens by Using the Amplicor Chlamydia trachomatis Assay. J Clin Microbiol. 1996; 34:3072-3074.Woods ML, Robinson EN Jr., McGee ZA, Hitchcok PJ. Chlamydiae-Genital and Respiratory Pathogens in Mechanisms of Microbial Disease. Shaechter M, Medoff G, Eisenstein B I. Second Edition. Williams & Wilkins. Baltimore, Maryland. USA. 1989; 350-357.https://revistamvz.unicordoba.edu.co/article/download/528/596Núm. 2 , Año 2001 : Revista MVZ Córdoba volumen 6(2) Julio-Diciembre 200126Revista MVZ CórdobaPublicationOREORE.xmltext/xml2569https://repositorio.unicordoba.edu.co/bitstreams/4ce1becb-566d-405f-95f2-e6c0c5da15ba/download3d791b0ad6968cbc0088d6252df219c8MD51ucordoba/5749oai:repositorio.unicordoba.edu.co:ucordoba/57492023-10-06 00:46:42.609https://creativecommons.org/licenses/by-nc-sa/4.0/metadata.onlyhttps://repositorio.unicordoba.edu.coRepositorio Universidad de Córdobabdigital@metabiblioteca.com

Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.

Publicaciones similares